All NeuroStar Better Me Providers (BMP) commit to attending NeuroStar University (NSU). We are incredibly proud that NSU attendees showed 58% greater utilization when compared to practices that did not attend, translating to more patients receiving potentially life-changing treatment. Invest in your practice and your patients' well-being. Ask your NeuroStar representative about joining NeuroStar University today! #NeuroStar #TMS #Therapy #MentalHealth #Training #Patients #Results www.neurostar.com
Neuronetics, Inc.’s Post
More Relevant Posts
-
Tap into a new possibility for adolescent depression! Introducing NeuroStar TMS, a NEW FDA-cleared first-line, add-on therapy for adolescents aged 15 and older. Proven safe and effective for adolescents! In a clinical study of 1,169 adolescent patients: 78% cited improvement in their depression symptoms* 48% showed symptom relief (remission)* Take action against depression. Learn more about NeuroStar TMS at Neurostar.com Visit NeuroStar.com for full safety and prescribing information. *FDA Clearance K231926 The outcomes reported represent the subset of study patients for which the CGI-S data was reported before and after an acute course of NeuroStar TMS. Patients aged 12 to 21 (average 19.2 ± 1.5) were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score ≤3 and “complete remission” was defined as a CGI-S score ≤2 at the end of treatment. #NeuroStarTMS #AdolescentMentalHealth #NeuroStarForAdolescents
To view or add a comment, sign in
-
July is BIPOC Mental Health Month, a time to recognize and address the unique challenges faced by BIPOC communities. NeuroStar Advanced TMS Therapy offers a non-drug, non-invasive option to help bridge the treatment gap. Explore how NeuroStar can positively impact the mental health journey for you or a loved one. #NeuroStar #MentalHealthMatters #BIPOCMentalHealthMonth
To view or add a comment, sign in
-
-
We're thrilled to announce the national launch of our Better Me Provider (BMP) program! Neuronetics is the first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry. NeuroStar providers in the program are committed to rigorous standards, developed in collaboration with a network of TMS medical experts. Learn more about the BMP program and its remarkable success https://lnkd.in/gCfGhBhs #NeuroStar #MentalHealth #PatientCare
To view or add a comment, sign in
-
-
Wondering what TMS therapy is all about? Watch our video and learn how NeuroStar TMS uses magnetic pulses to safely and effectively treat depression, anxiety that accompanies depression, and OCD. What questions do you have about TMS therapy? Leave a comment below! Visit NeuroStar.com or the link in bio to learn more. #TMStherapy #MentalHealthAwareness #NeuroStar
To view or add a comment, sign in
-
NeuroStar's Better Me Provider (BMP) pilot program is designed to set the standard for patient care in the industry. Ask a NeuroStar representative how it can make a difference in your practice today. #NeuroStar #MentalHealth #PatientCare
To view or add a comment, sign in
-
-
Thank you, Vogue, for raising awareness about adolescent depression and highlighting the potential of NeuroStar TMS treatment. With 42% of US high schoolers experiencing persistent sadness¹, NeuroStar TMS, a noninvasive procedure using magnetic fields to stimulate nerve cells in the brain, offers new hope with a 62% remission rate in depression symptoms.² FDA-cleared for adolescents aged 15 and up, it provides a promising alternative to medication. Learn more about NeuroStar TMS at NeuroStar.com and how it can help you or a loved one struggling with depression. #NeuroStarTMS #AdolescentMentalHealth #NeuroStarForAdolescents 1. Centers for Disease Control and Prevention. (2022). Youth Risk Behavior Survey Data Summary & Trends Report: 2011-2021. 2. FDA Clearance K231926 (2024). The outcomes reported represent the subset of study patients for which the CGI-S and GAD-7 data was reported before and after an acute course of NeuroStar TMS. Patients aged 12 to 21 (average 19.2 ± 1.5) were treated under real-world conditions where patients may have been prescribed concomitant depression treatments including medications. “Measurable relief” was defined as a CGI-S score ≤3 and “complete remission” was defined as a CGI-S score ≤2 at the end of treatment.
To view or add a comment, sign in
-
-
On Juneteenth, let's celebrate, learn, and grow, honoring the strength and resilience of the Black community. If you or someone you know is battling depression, reach out for help. NeuroStar TMS offers non-drug, non-invasive treatment, free from common systemic side effects of medication. Visit NeuroStar.com to find a NeuroStar TMS doctor near you. #NeuroStar #NeuroStarConnects #Juneteenth #NeuroStarSocial
To view or add a comment, sign in
-
Dads are strong, supportive, and often the rock of the family. But sometimes, even the strongest need help. This Father's Day, let's show the dads in our lives that it's okay to ask for help. Learn more about NeuroStar TMS therapy as a safe and effective treatment option for depression, depression with anxiety, and OCD. Visit NeuroStar.com #MensHealthMatters #NeuroStarTMS #FathersDay
To view or add a comment, sign in
-
Are you looking to transform the lives of more patients with NeuroStar? Our Better Me Provider (BMP) pilot program is designed to help you do just that. By following the 5-Standards, BMP providers are helping transform the lives of 3.6x more new patients with NeuroStar than non-program participants. To learn more about the program, contact a NeuroStar representative today. #NeuroStar #BetterMeProviders #MentalHealth
To view or add a comment, sign in
-
Senior Director, Commercial Excellence and Education
4dBravo!